This research combination includes
CJC-1295 (without DAC) and
Ipamorelin, two peptides commonly studied in growth hormone signaling research.
CJC-1295 (No DAC)
CJC-1295 without Drug Affinity Complex (DAC) is a shorter-acting analog of
Growth Hormone Releasing Hormone (GHRH).
It is investigated for:
- Pulsatile growth hormone release stimulation
- IGF-1 pathway research
- Endocrine signaling modulation
Ipamorelin
Ipamorelin is a selective growth hormone secretagogue studied for:
- Ghrelin receptor (GHS-R1a) activation
- Stimulation of growth hormone secretion
- Minimal impact on cortisol and prolactin pathways (in research models)
Research Applications
- Growth hormone axis investigations
- IGF-1 signaling studies
- Recovery and tissue regeneration models
- Endocrine modulation research
For research use only. Not for human consumption.